NM_001289.6:c.478C>G

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001289.6(CLIC2):​c.478C>G​(p.Pro160Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00276 in 1,206,993 control chromosomes in the GnomAD database, including 8 homozygotes. There are 1,024 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0021 ( 0 hom., 76 hem., cov: 23)
Exomes 𝑓: 0.0028 ( 8 hom. 948 hem. )

Consequence

CLIC2
NM_001289.6 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.217

Publications

4 publications found
Variant links:
Genes affected
CLIC2 (HGNC:2063): (chloride intracellular channel 2) This gene encodes a chloride intracellular channel protein. Chloride channels are a diverse group of proteins that regulate fundamental cellular processes including stabilization of cell membrane potential, transepithelial transport, maintenance of intracellular pH, and regulation of cell volume. This protein plays a role in inhibiting the function of ryanodine receptor 2. A mutation in this gene is the cause of an X-linked form of cognitive disability. [provided by RefSeq, Jul 2017]
CLIC2 Gene-Disease associations (from GenCC):
  • X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome
    Inheritance: XL, Unknown Classification: MODERATE, SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006031245).
BP6
Variant X-155279253-G-C is Benign according to our data. Variant chrX-155279253-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 197724.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 76 XL,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLIC2NM_001289.6 linkc.478C>G p.Pro160Ala missense_variant Exon 5 of 6 ENST00000369449.7 NP_001280.3 O15247

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLIC2ENST00000369449.7 linkc.478C>G p.Pro160Ala missense_variant Exon 5 of 6 1 NM_001289.6 ENSP00000358460.2 O15247
CLIC2ENST00000321926.4 linkc.352C>G p.Pro118Ala missense_variant Exon 4 of 4 3 ENSP00000318558.4 A6PVS0
CLIC2ENST00000465553.5 linkn.593C>G non_coding_transcript_exon_variant Exon 5 of 7 3
CLIC2ENST00000491205.1 linkn.*16C>G downstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.00214
AC:
239
AN:
111938
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000325
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00303
Gnomad ASJ
AF:
0.00302
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00854
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00254
Gnomad OTH
AF:
0.00133
GnomAD2 exomes
AF:
0.00264
AC:
484
AN:
183149
AF XY:
0.00250
show subpopulations
Gnomad AFR exome
AF:
0.0000761
Gnomad AMR exome
AF:
0.00106
Gnomad ASJ exome
AF:
0.00227
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0104
Gnomad NFE exome
AF:
0.00318
Gnomad OTH exome
AF:
0.00244
GnomAD4 exome
AF:
0.00283
AC:
3096
AN:
1095004
Hom.:
8
Cov.:
29
AF XY:
0.00263
AC XY:
948
AN XY:
360482
show subpopulations
African (AFR)
AF:
0.000607
AC:
16
AN:
26347
American (AMR)
AF:
0.000937
AC:
33
AN:
35202
Ashkenazi Jewish (ASJ)
AF:
0.00269
AC:
52
AN:
19365
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54063
European-Finnish (FIN)
AF:
0.0115
AC:
465
AN:
40515
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4130
European-Non Finnish (NFE)
AF:
0.00288
AC:
2415
AN:
839180
Other (OTH)
AF:
0.00250
AC:
115
AN:
46006
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
107
215
322
430
537
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00213
AC:
239
AN:
111989
Hom.:
0
Cov.:
23
AF XY:
0.00222
AC XY:
76
AN XY:
34169
show subpopulations
African (AFR)
AF:
0.000324
AC:
10
AN:
30822
American (AMR)
AF:
0.00303
AC:
32
AN:
10569
Ashkenazi Jewish (ASJ)
AF:
0.00302
AC:
8
AN:
2648
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3561
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2655
European-Finnish (FIN)
AF:
0.00854
AC:
52
AN:
6086
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.00254
AC:
135
AN:
53218
Other (OTH)
AF:
0.00131
AC:
2
AN:
1523
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00225
Hom.:
45
Bravo
AF:
0.00162
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00346
AC:
10
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00297
AC:
20
ExAC
AF:
0.00262
AC:
318

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 30, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 25, 2014
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.059
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
3.1
DANN
Benign
0.34
DEOGEN2
Benign
0.15
T;T
FATHMM_MKL
Benign
0.24
N
LIST_S2
Benign
0.75
T;T
M_CAP
Benign
0.060
D
MetaRNN
Benign
0.0060
T;T
MetaSVM
Benign
-0.66
T
MutationAssessor
Benign
-1.5
N;.
PhyloP100
0.22
PrimateAI
Benign
0.37
T
PROVEAN
Benign
3.0
N;N
REVEL
Benign
0.14
Sift
Benign
0.67
T;T
Sift4G
Benign
0.75
T;T
Polyphen
0.0090
B;.
Vest4
0.10
MVP
1.0
MPC
0.56
ClinPred
0.0084
T
GERP RS
0.56
Varity_R
0.11
gMVP
0.24
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41304992; hg19: chrX-154508542; API